ALMS
AlumisBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ALMS vs peer average
66/100
ALMS vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
Dermatology-biotech comp with more commercial footing; useful for framing how psoriasis assets trade once clinical validation starts translating into launch expectations.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALMS
Alumis
ARQT
Arcutis Biotherapeutics
Grade
B
B
Momentum
96
84
Value
41
49
Sentiment
49
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ARQT
ALMS / ARQT
Grade Position
In line
ALMS vs. peer average (B vs. C)
66/100
Momentum
96
ALMSValue
41
ARQTSentiment
49
ALMSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALMS
ARQT is the first peer returned for this comparison set.